Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06972706 · ClinicalTrials.gov registry record · NA
Efficacy and Safety of Shatavari in Women Sexual Wellness: A Prospective, Randomized, Double-Blind, Three-arm, Parallel, Placebo-Controlled Study
A NA study, sponsored by SF Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT06972706 is a NA study that has completed, run by SF Research Institute. The registered enrollment target is 51 participants.
The verdict
NCT06972706, a NA study, has completed, sponsored by SF Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
This is a Multi-center, Multi-national, Prospective, Randomized, Double-Blind, Placebo- Controlled three arm study to evaluate the efficacy and safety of Shatavari in Women Sexual Wellness. Participants will be randomized to either one of the three treatment arms.Participants will then be asked to either take one capsule containing Shatavari or Shatavari + Ashwagandha or Placebo orally once daily in the morning after breakfast with a glass of water for 8 weeks. All the subjects will be asked to continue their routine diet and physical activities during the whole study period. The primary objective is to assess the efficacy of Shatavari capsules for improvement in Women Sexual Wellness. The secondary objective is to assess the safety of Shatavari capsules in healthy women.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Shatavari + Ashwagandha extract
- DIETARY_SUPPLEMENT Shatavari
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2024-10-26 |
| Est. Completion | 2025-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06972706
The ClinicalTrials.gov registry entry for NCT06972706 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SF Research Institute, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT06972706 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06972706 about?
NCT06972706 is a clinical study titled "Efficacy and Safety of Shatavari in Women Sexual Wellness: A Prospective, Randomized, Double-Blind, Three-arm, Parallel, Placebo-Controlled Study". This is a Multi-center, Multi-national, Prospective, Randomized, Double-Blind, Placebo- Controlled three arm study to evaluate the efficacy and safety of Shatavari in Women Sexual Wellness. Participants will be randomized to either one of the three treatment arms.Participants will then be asked to e...
What is the current status of trial NCT06972706?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2024-10-26. Estimated completion is 2025-02-28.
What interventions are being tested in trial NCT06972706?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Shatavari + Ashwagandha extract (DIETARY_SUPPLEMENT), Shatavari (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06972706?
This trial is sponsored by SF Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.